Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Corporate Governance Report
Notice of Receipt of Dividend from JTs Consolidated Subsidiary
2025 Full Year Results & 2026 Forecast (All Presentation)
Consolidated Financial Results for the Fiscal Year Ended December 31,2025 <under IFRS>
Notice Regarding Completion of JT Group’s Pharmaceutical Business to Shionogi & Co., Ltd. through a Company Simplified Absorption-Type Split
JT Announces New Executive Appointments
(Correction) Partial Correction of “Notice concerning revised dividends”
2025 Third Quarter Results (CFO Presentation)
Notice concerning revision of year-end dividend guidance
Consolidated Financial Results for the Nine Months Ended September 30,2025 <under IFRS>
Notice Regarding the Conclusion of an Absorption-Type Split Contract Related to the Transfer of JT Group's Pharmaceutical Business
Notice of the Completion of New Issuance and Tender Offer of Foreign Currency Denominated Subordinated Bond by JT’s Foreign Subsidiary
Notice Regarding Completion of Transfer of Subsidiary Shares
Notice of New Issuance and Tender Offer of Foreign Currency Denominated Subordinated Bonds by JT’s Foreign Subsidiary
Notice of Receipt of Dividend from JT's Consolidated Subsidiary
Partial re-correction of “2024 Full Year Results & 2025 Forecasts (All Presentation)”
Notice concerning increase of dividends of surplus and revise of dividend forecast
Consolidated Financial Results for the Six Months Ended June 30, 2025 <under IFRS>
2025 Second Quarter Results (CFO Presentation)
Integrated Report 2025